Nome del prodotto |
DL-Laudanosine |
Sinonimi |
Isoquinoline, 1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratryl-, (+-)-; (+-)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinoline; (+-)-Laudanosine; AI3-61890; NSC 94267; (1)-1-((3,4-Dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinoline; Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (+-)- (9CI); (1S)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium; (1R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium |
Formula molecolare |
C21H28NO4 |
Peso Molecolare |
358.4508 |
InChI |
InChI=1/C21H27NO4/c1-22-9-8-15-12-20(25-4)21(26-5)13-16(15)17(22)10-14-6-7-18(23-2)19(11-14)24-3/h6-7,11-13,17H,8-10H2,1-5H3/p+1/t17-/m1/s1 |
Numero CAS |
1699-51-0 |
EINECS |
216-923-9 |
Struttura molecolare |
|
Punto di fusione |
113-115℃ |
Punto di ebollizione |
468.1°C at 760 mmHg |
Punto d'infiammabilità |
131.2°C |
Simboli di pericolo |
|
Codici di Rischio |
|
Sicurezza Descrizione |
S24/25:Avoid contact with skin and eyes.;
|
|